Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
NHE1 in Macrophages Drives Octanal/Olfr2-Induced Atheroscler
2026-05-29
The study unveils how sodium-hydrogen exchanger 1 (NHE1) in macrophages acts as a key mediator of atherosclerosis driven by octanal-activated Olfr2, via calcium-dependent ROS and NLRP3 inflammasome activation. These mechanistic findings highlight NHE1 as a potential therapeutic target for modulating inflammation in cardiovascular disease.
-
Tiamulin (Thiamutilin): Applied Workflows for Veterinary and
2026-05-29
Tiamulin (Thiamutilin) is a pleuromutilin antibiotic uniquely positioned for both infectious disease control in livestock and emerging anti-inflammatory applications. This article delivers hands-on workflow guidance, optimization strategies, and troubleshooting insights for maximizing experimental success with APExBIO's Tiamulin, drawing on published evidence and recent advances in ribosomal mechanism elucidation.
-
Sulfo-NHS-SS-Biotin: Precision Reversible Cell Surface Label
2026-05-28
The Sulfo-NHS-SS-Biotin Kit from APExBIO sets a new standard for reversible cell surface protein labeling, enabling selective, high-fidelity tagging and purification. Its unique disulfide-cleavable spacer and water solubility empower advanced workflows in proteomics, interactome mapping, and dynamic cell surface studies.
-
AG-221 (Enasidenib): Reliable Solutions for AML Research Wor
2026-05-28
This article delivers evidence-based strategies for acute myeloid leukemia research using AG-221 (Enasidenib, SKU B7804). It addresses real-world experimental challenges—ranging from assay reproducibility to metabolic resistance—demonstrating how AG-221 enables sensitive, data-backed workflows and reliable cell differentiation outcomes.
-
Trichostatin A (TSA): Epigenetic Precision in Organoid and C
2026-05-27
Explore how Trichostatin A (TSA) enables precise epigenetic modulation in advanced organoid systems and cancer models. This article reveals new assay strategies and practical insights, building on recent breakthroughs in self-renewal and differentiation control.
-
Applied Use of (-)-Blebbistatin in Non-Muscle Myosin II Stud
2026-05-27
(-)-Blebbistatin from APExBIO enables precise, reversible inhibition of non-muscle myosin II, empowering researchers to dissect cytoskeletal and mechanotransduction processes with minimal off-target effects. Advanced workflow integration and troubleshooting tips ensure robust results in cell adhesion, migration, and force-transduction studies.
-
Copper-Coordinated Nanoassemblies Induce Cuproptosis in Canc
2026-05-26
This study introduces a baicalein–copper nanoassembly integrating chemodynamic and photodynamic modalities to induce cuproptosis—a copper-triggered form of cell death—for cancer therapy. The platform achieves efficient bone-penetration, selective tumor targeting, and robust generation of highly reactive oxygen species, providing a promising strategy for overcoming key limitations of current cancer treatments.
-
MG-132 (Z-LLL-al): Precision Tools for Apoptosis and Cell Cy
2026-05-26
MG-132 (Z-LLL-al) stands out as a highly selective, cell-permeable proteasome inhibitor critical for dissecting apoptosis and cell cycle arrest mechanisms in cancer and neurobiology research. This guide delivers actionable workflows, troubleshooting insights, and data-driven context for maximizing experimental control with MG-132, as supported by advanced literature and the latest T-cell research.
-
I-BET151 (GSK1210151A): Unlocking BET Inhibition for Disulfi
2026-05-25
Explore how I-BET151 (GSK1210151A) empowers advanced cancer research by targeting BET bromodomains, with a special focus on disulfidptosis and the super-enhancer landscape. This article uniquely bridges mechanistic insight with practical assay guidance for apoptosis and cell cycle arrest.
-
ERK Signaling Drives IFNγ-Induced Apoptosis in Melanoma Cell
2026-05-25
Champhekar et al. reveal that ERK activation is essential for interferon gamma (IFNγ)-mediated cell death in melanoma. Their integrative genomic and functional analysis defines a mechanistic link between immune cytokine signaling and apoptosis, informing strategies for overcoming resistance in cancer immunotherapy.
-
2,5-di-tert-butylbenzene-1,4-diol: Precision in SERCA Inhibi
2026-05-24
2,5-di-tert-butylbenzene-1,4-diol (BHQ) offers researchers unparalleled control in calcium signaling and stem cell mobilization assays, leveraging selective SERCA inhibition. Grounded in recent mechanistic discoveries, BHQ empowers translational research by optimizing experimental reproducibility and providing novel directions for therapeutic applications.
-
Balancing Self-Renewal and Differentiation in Human Intestin
2026-05-23
This study presents an optimized human intestinal organoid system that achieves a controlled balance between stem cell self-renewal and differentiation using small molecule pathway modulators. The approach enhances cellular diversity and proliferative capacity under a single culture condition, addressing a key challenge in organoid-based disease modeling and high-throughput screening.
-
O-GlcNAcylation Rewires Glycolysis for Wnt-Driven Bone Forma
2026-05-22
This study uncovers how O-GlcNAcylation, a protein modification, is necessary for Wnt-stimulated bone formation by regulating aerobic glycolysis in osteoblasts. The findings reveal a metabolic mechanism linking Wnt signaling to bone anabolism, providing new avenues for skeletal and metabolic research.
-
WP1066: Potent JAK2/STAT3 Inhibitor for Oncology and Regener
2026-05-22
WP1066 is a cell-permeable JAK2/STAT3 inhibitor that blocks phosphorylation and downstream signaling, showing efficacy in renal cell carcinoma and acute myeloid leukemia models. Its activity extends to inhibition of tumor angiogenesis and modulation of macrophage-driven bone regeneration pathways.
-
0.4% Trypan Blue Solution: Technical Guide for Cell Viabilit
2026-05-21
0.4% Trypan Blue Solution provides researchers with a straightforward, membrane-integrity-based method for live/dead cell discrimination and viability measurement in cell culture workflows. It is not intended for diagnostic or medical applications, and its reliability depends on correct handling and appropriate assay context.